Researchers at UCI have developed an implantable medical device for monitoring patient analytes. One application for the device is to continuously measure analytes and oxygen in trauma patients. This biosensor affords rapid and accurate continuous measurements of molecules critical for assessing patient status in clinical settings. This device may also be adapted to measure other analytes, such as glucose, for long-term disease management.
Measurement of analytes in the body, such as oxygen, carbon dioxide, sugars, and metabolic products, is critical for physicians to assess a patient’s medical status and determine treatment options. Several commercial systems exist for measuring medical analytes in a hospital or lab setting. These systems use bench-top instruments that sample blood or other biological fluids at discrete time points. For many medical conditions, however, a continuous measurement of analytes would provide real-time dynamic information that may better assist a physician or patient in making treatment decisions.
Researchers have developed a platform technology to continuously measure the concentration of multiple analytes in vivo. This invention is a small (less than 1 mm) biosensor probe that is implanted under a patient’s skin, producing rapid, continuous measurements using optically-active dyes or enzymes inside the device. The probe can wirelessly transmit measurement results to allow for hands-off access to real-time information of the analyte of interest. . Analytes that this technology can measure include glucose, lactic acid, ketones, oxygen, carbon dioxide, and more. The ability to measure these dynamic molecules in the body in a real-time, accurate method will provide healthcare professionals better information for making improved medical decisions.
The figure below demonstrates the ability of our continuous analyte monitor to accurately detect a specific analyte when compared to a blood sample.
Acellular studies were completed to confirm the sensor's ability to respond in real-time to analytes in a buffer solution.
In vivo (rat and rabbit) studies were also performed. The implanted device successfully measured accurate, real-time analyte concentrations in the blood in response to a stimulus. Results were compared against commercial devices using drawn blood.
A human clinical study has been completed with a first prototype device to demonstrate the sensor's ability to accurately track analyte measurements with those obtained by a standard blood draw.
Human clinical studies will be repeated with a miniaturized second generation prototype of the device.
- In-body analyte sensor for diagnostic and therapeutic applications
- Improved medical monitoring capabilities
o The implanted biosensor gives real-time, rapid, and accurate results of analytes in the body
o Can be employed for short-term (i.e. hospital) or long-term (i.e. chronic illness) management
- More convenient and comfortable method for patients and physicians
o Eliminates the need for frequent blood draws
o Requires only one minimally-invasive out-patient procedure (implantation of the small device under the skin)
- Can be used to simultaneously measure glucose, carbon dioxide, and more.
|United States Of America||Issued Patent||10,750,985||08/25/2020||2013-017|
biosensor, trauma, analyte, monitor, lactic acid, glucose